Trilaminar Cells plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Hippocampal trilaminar cells represent a distinctive and relatively rare population of hippocampal interneurons characterized by their unique axonal projection pattern. These neurons derive their name from the trilaminar (three-layered) organization of their axonal arborization within the hippocampal formation. First described by Sik and colleagues in the mid-1990s, trilaminar cells have emerged as critical modulators of hippocampal output pathways, particularly influencing information flow between the hippocampus and subiculum. Their strategic positioning and specific connectivity patterns suggest important roles in hippocampal-dependent learning, memory consolidation, and spatial processing. [1]
The hippocampus contains over 20 morphologically and neurochemically distinct interneuron populations, each contributing to the precise temporal coordination of pyramidal cell activity. Trilaminar cells occupy a unique niche within this diverse interneuron ecosystem, functioning as principal cells that mediate long-range communication between hippocampal subfields and downstream targets. [2]
Trilaminar cells exhibit distinctive morphological characteristics that distinguish them from other hippocampal interneurons: [3]
Somatic properties: [4]
Dendritic architecture: [5]
Axonal projection pattern (defining characteristic): [6]
The tripartite axonal arborization gives trilaminar cells their name: [7]
This trilaminar axonal pattern allows trilaminar cells to innervate pyramidal neurons at multiple positions along their somatodendritic axis, providing powerful and distributed inhibition. [8]
Trilaminar cells are found throughout the hippocampal formation: [9]
Their distribution suggests region-specific functions in hippocampal circuitry, with CA1 trilaminar cells likely influencing information flow toward the subiculum.
Trilaminar cells preferentially target specific neuronal populations:
The_postsynaptic targets of trilaminar cells are predominantly principal (pyramidal) neurons, positioning these cells as key regulators of hippocampal output.
Trilaminar cells express specific combinations of molecular markers:
| Marker | Expression | Significance |
|---|---|---|
| Parvalbumin (PV) | Variable | Calcium buffering |
| Calretinin (CR) | Often positive | Calcium binding |
| Calbindin (CB) | Sometimes present | Calcium homeostasis |
| Somatostatin (SOM) | Subpopulation | Neuropeptide signaling |
| NPY | Some cells | Neuropeptide modulation |
| VIP | Rare | Peptidergic modulation |
The neurochemical diversity within the trilaminar cell population suggests functional heterogeneity, with different subpopulations potentially serving distinct computational roles.
Single-cell transcriptomic studies reveal distinct gene expression patterns:
This molecular profile supports the unique electrophysiological properties and connectivity patterns of trilaminar cells.
Trilaminar cells express diverse receptor populations:
This receptor diversity allows trilaminar cells to integrate various neuromodulatory signals.
Trilaminar cells display characteristic electrophysiological properties:
Trilaminar cells exhibit diverse firing behaviors:
Fast-spiking phenotype:
Regular-spiking pattern:
Burst firing:
Trilaminar cells receive diverse synaptic inputs:
Excitatory inputs:
Inhibitory inputs:
This synaptic architecture enables trilaminar cells to function as both feedforward and feedback inhibitors.
Trilaminar cells play crucial roles in regulating hippocampal output:
Trilaminar cells contribute to spatial information processing:
Through their subicular projections, trilaminar cells influence:
Trilaminar cells contribute to hippocampal oscillations:
Trilaminar cells are affected in AD through multiple mechanisms:
Pathological changes:
Circuit dysfunction:
Mechanisms:
Therapeutic implications:
While primarily a basal ganglia disorder, PD affects hippocampal trilaminar cells:
Trilaminar cell dysfunction contributes to epileptogenesis:
Frontotemporal Dementia:
Vascular Dementia:
Huntington's Disease:
Trilaminar cell dysfunction contributes to:
While not directly measurable clinically, trilaminar cell function may be assessed through:
Targeting trilaminar cells offers therapeutic potential:
Studying trilaminar cells employs various approaches:
In vitro preparations:
In vivo models:
Computational models:
Trilaminar Cells plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Trilaminar Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Jinno S, et al. Neuronal diversity in the hippocampus. Prog Brain Res. 2007. 2007. ↩︎
Freund TF, Buzsáki G. Interneurons of the hippocampus. Hippocampus. 1996. 1996. ↩︎
Klausberger T, Somogyi P. Neuronal diversity and temporal dynamics in the hippocampus. Science. 2008. 2008. ↩︎
Pelkey KA, et al. Hippocampal GABAergic Inhibitory Interneurons. Physiol Rev. 2017. 2017. ↩︎
Hu JS, et al. Parvalbumin-expressing interneurons coordinate hippocampal network dynamics. Nat Neurosci. 2022. 2022. ↩︎
Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. 2016. 2016. ↩︎
Busche MA, Hyman CA. Synergy between amyloid-β and tau in Alzheimer's disease. Nat Neurosci. 2020. 2020. ↩︎
Palop JJ, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron. 2007. 2007. ↩︎
Verret L, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012. 2012. ↩︎